These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36743163)

  • 21. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors of latent tuberculosis among Korean healthcare workers using whole-blood interferon-γ release assay.
    Yeon JH; Seong H; Hur H; Park Y; Kim YA; Park YS; Han CH; Lee SM; Seo JH; Kang JG
    Sci Rep; 2018 Jul; 8(1):10113. PubMed ID: 29973678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
    Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
    Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States.
    Annan E; Stockbridge EL; Katz D; Mun EY; Miller TL
    Medicine (Baltimore); 2021 Feb; 100(7):e24838. PubMed ID: 33607853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent Tuberculosis Infection Diagnosis among Household Contacts in a High Tuberculosis-Burden Area: a Comparison between Transcript Signature and Interferon Gamma Release Assay.
    Kaul S; Nair V; Birla S; Dhawan S; Rathore S; Khanna V; Lohiya S; Ali S; Mannan S; Rade K; Malhotra P; Gupta D; Khanna A; Mohmmed A
    Microbiol Spectr; 2022 Apr; 10(2):e0244521. PubMed ID: 35416716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening.
    Lim RK; Talavlikar R; Chiazor O; Bietz J; Gardiner H; Fisher D
    BMC Infect Dis; 2021 Sep; 21(1):936. PubMed ID: 34503458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
    Sabri A; Quistrebert J; Naji Amrani H; Abid A; Zegmout A; Abderrhamani Ghorfi I; Souhi H; Boucaid A; Benali A; Abilkassem R; Kmari M; Hassani A; Lahcen B; Siah S; Schurr E; Boisson-Dupuis S; Casanova JL; Lahlou A; Laatiris A; Louzi L; Ouarssani A; Bourazza A; Aouragh A; Mustapha B; Messaoudi N; Agader A; Cobat A; Abel L; El Baghdadi J
    PLoS One; 2019; 14(8):e0221081. PubMed ID: 31415649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.
    Adams JW; Howe CJ; Andrews AC; Allen SL; Vinnard C
    AIDS Care; 2017 Dec; 29(12):1504-1509. PubMed ID: 28486818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment.
    Yoopetch P; Chitpim N; Jittikoon J; Udomsinprasert W; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Chaikledkaew U
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
    Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
    BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study.
    Song YJ; Cho SK; Kim H; Kim HW; Nam E; Bae SC; Yoo DH; Sung YK
    J Korean Med Sci; 2021 Mar; 36(10):e70. PubMed ID: 33724737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of latent tuberculosis infection in rural Jiangsu, China.
    Liu Y; Huang S; Jiang H; Xiong J; Wang Y; Ou M; Cai J; Yang C; Wang Z; Ge S; Xia N
    Public Health; 2017 May; 146():39-45. PubMed ID: 28404472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
    Campbell JR; Krot J; Elwood K; Cook V; Marra F
    Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First assessment of interferon gamma release assay results among healthcare workers at a general hospital in China.
    Guo LP; Jiang Y; Liu YM; Cao B
    Clin Respir J; 2018 Nov; 12(11):2581-2589. PubMed ID: 30232836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test.
    He Y; Cao X; Guo T; He Y; Du Y; Zhang H; Feng B; Du J; Zhang B; Wang K; Yan J; Wang D; Liu Z; Pan S; Xin H; Gao L
    Front Public Health; 2022; 10():1025550. PubMed ID: 36530654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing tuberculosis screening for immigrants in southern New Brunswick: A pilot study protocol.
    Shamputa IC; Nguyen DTK; Higazy D; Abdelhadi A; MacKenzie H; Reddin M; Barker K; Webster D
    PLoS One; 2022; 17(11):e0277255. PubMed ID: 36331954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.